Facial Bradykinesia
JNNP 84:681-685, Bologna, M.,et al, 2013
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations
AJNR 37:774-781, Winton-Brown, T.T.,et al, 2016
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Ophthalmologic Features of Parkinson's Disease
Neurol 62:177-180, Biousse,V.,et al, 2004
Glabellar and Palmomental Reflexes in Parkinsonian Disorders
Neurol 63:1096-1098, Brodsky,H.,et al, 2004
Therapies for Movement Disorders
Arch Neurol 59:699-702, Goetz,C.G &Hinson,V.K., 2002
The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994
Post-Traumatic Movement Disorders:Central and Peripheral Mechanisms
Neurol 44:2006-2014, Jankovic,J., 1994
Idiopathic Hemiparetic Parkinsonism, A Syndrome Distinct from Idiopathic Parkinsonism
Lancet 339:149-150, DeKeyser,J.,et al, 1992
Essential Tremor:Clinical Correlates in 350 Patients
Neurol 41:234-238, Lou,J.&Jankovic,J., 1991
Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991
Blink Rates in Parkinsonism
Ann Neurol 12:580-583, Karson,C.N.,et al, 1982
Amyloid Neuropathy & Tremor in Waldenstrom's Macroglobulinemia
Arch Neurol 37:240-242, Bajada,S.,et al, 1980
Azorean Disease of the Nervous System
NEJM 296:1505, Romanul,F.C.A.,et al, 1977
Elevated Manganese Levels Associated with Dementia & Extrapyramidal Signs
Neurol 27:213, Banta,R.G.,et al, 1977
Normocalcemic Tetany
Neurol 26:825, Isgreen,W.P., 1976
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Parkinson's Disease
In Handbk of Clinical Neurology, Vinken, P. J. & Bruyn, G. W. , Ed, North-Holland Publ Co, Amsterdam, 6:173, 1968. Selby, G., 1968